Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Strange

Showing results (241-250 of 274) with videos related to

Pageof 28
Sort By:
Environmental and Molecular Mutagenesis|November 10, 2004
PTCH polymorphism is associated with the rate of increase in basal cell carcinoma numbers during follow-up: preliminary data on the influence of an exon 12-exon 23 haplotypeRichard C Strange, Noha El-Genidy, Sudarshan Ramachandran, et al.
Pharmacogenetics|September 7, 2000
Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumoursS Ramachandran, P R Hoban, F Ichii-Jones, et al.
Cancer Letters|November 10, 2004
Associations between UVR exposure and basal cell carcinoma site and histologyTracy J Lovatt, John T Lear, Jean Bastrilles, et al.
Annals of Human Genetics|December 16, 2004
Susceptibility to basal cell carcinoma: associations with PTCH polymorphismsR C Strange, N El-Genidy, S Ramachandran, et al.
Carcinogenesis|September 1, 1996
Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrualJ T Lear, A H Heagerty, A Smith, et al.
The British Journal of Dermatology|March 29, 2000
Preliminary evidence of an association of tumour necrosis factor microsatellites with increased risk of multiple basal cell carcinomasA H Hajeer, J T Lear, W E Ollier, et al.
Pharmacogenetics|February 18, 1999
Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancersC Matthias, U Bockmühl, V Jahnke, et al.
Pharmacogenetics|April 30, 2004
Glutathione-S-transferase M1, M3, P1 and T1 polymorphisms and severity of lung disease in children with cystic fibrosisCyril Flamant, Alexandra Henrion-Caude, Pierre-Yves Boëlle, et al.
Pharmacogenetics|September 2, 1999
Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanomaR C Strange, T Ellison, F Ichii-Jones, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 29, 2003
Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC studyK M Smits, L Gaspari, M P Weijenberg, et al.
Pageof 28

Showing results (241-250 of 274) with videos related to

Sort By:
Pageof 28
Environmental and Molecular Mutagenesis|November 10, 2004
PTCH polymorphism is associated with the rate of increase in basal cell carcinoma numbers during follow-up: preliminary data on the influence of an exon 12-exon 23 haplotypeRichard C Strange, Noha El-Genidy, Sudarshan Ramachandran, et al.
Pharmacogenetics|September 7, 2000
Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumoursS Ramachandran, P R Hoban, F Ichii-Jones, et al.
Cancer Letters|November 10, 2004
Associations between UVR exposure and basal cell carcinoma site and histologyTracy J Lovatt, John T Lear, Jean Bastrilles, et al.
Annals of Human Genetics|December 16, 2004
Susceptibility to basal cell carcinoma: associations with PTCH polymorphismsR C Strange, N El-Genidy, S Ramachandran, et al.
Carcinogenesis|September 1, 1996
Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrualJ T Lear, A H Heagerty, A Smith, et al.
The British Journal of Dermatology|March 29, 2000
Preliminary evidence of an association of tumour necrosis factor microsatellites with increased risk of multiple basal cell carcinomasA H Hajeer, J T Lear, W E Ollier, et al.
Pharmacogenetics|February 18, 1999
Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancersC Matthias, U Bockmühl, V Jahnke, et al.
Pharmacogenetics|April 30, 2004
Glutathione-S-transferase M1, M3, P1 and T1 polymorphisms and severity of lung disease in children with cystic fibrosisCyril Flamant, Alexandra Henrion-Caude, Pierre-Yves Boëlle, et al.
Pharmacogenetics|September 2, 1999
Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanomaR C Strange, T Ellison, F Ichii-Jones, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 29, 2003
Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC studyK M Smits, L Gaspari, M P Weijenberg, et al.
Pageof 28